Notes - Segment Information

Astellas Pharma Inc. - Filing #7358593

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Notes - Segment information
Segment information
Revenue
Revenue
1,189,070,000,000 JPY
421,932,000,000 JPY
1,164,365,000,000 JPY
402,180,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-461,000,000 JPY
-223,000,000 JPY
1,371,000,000 JPY
-407,000,000 JPY
Profit (loss) before tax
73,630,000,000 JPY
17,313,000,000 JPY
180,238,000,000 JPY
59,758,000,000 JPY
Assets
3,368,682,000,000 JPY
2,456,518,000,000 JPY
Investments accounted for using equity method
15,636,000,000 JPY
12,689,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.